Abstract: The present invention provides splice variants of myostatin that promote muscle growth, and include polynucleotides and polypeptide sequences, constructs comprising the sequences and compositions for regulating muscle growth and treating diseases associated with muscle tissue. The splice variants include the consensus sequence X1 I F L E X2 X3 X4 Q X5 C S I L X6 X7 X8 X9 X10 wherein X1 is I or L, X2 is V or L, X3 is Y, C, G or S, X4 is I or F, X5 is F or L, X6 is G or E, X7 is E or V, X8 is A or T, X9 is A or V and X10 is absent, F or L. The present invention also provides for the use of the present sequences in identifying animals with altered muscle mass, and for use in selective breeding programs to produce animals with altered muscle mass.
Type:
Application
Filed:
April 12, 2011
Publication date:
October 20, 2011
Applicant:
ORICO LIMITED
Inventors:
Ferenc Jeanplong, Christopher David McMahon
Abstract: The present invention relates to a method of treating sarcopenia in a human or animal patient by inhibiting the activity of myostatin using one or more myostatin antagonists.
Type:
Application
Filed:
February 7, 2006
Publication date:
May 28, 2009
Applicant:
Orico Limited
Inventors:
Ravi Kambadur, Mridula Sharma, Alex Hennebry, Monica Senna Salerno de Moura
Abstract: The present invention relates to a method of improving wound healing in a human or animal patient by inhibiting the activity of myostatin (GDF-8) using one or more myostatin antagonists. The present invention also relates to a method of treating fibrotic diseases or disorders comprising administering a myostatin antagonist.
Type:
Application
Filed:
February 7, 2006
Publication date:
August 7, 2008
Applicant:
ORICO LIMITED
Inventors:
Ravi Kambadur, Mridula Sharma, Alex Hennebry, Monica Senna Salerno de Moura
Abstract: The present invention provides splice variants of myostatin that promote muscle growth, and include polynucleotides and polypeptide sequences, constructs comprising the sequences and compositions for regulating muscle growth and treating diseases associated with muscle tissue. The splice variants include the consensus sequence X1 I F L E X2 X3 X4 Q X5 C S I L X6 X7 X8 X9 X10 wherein X1 is I or L, X2 is V or L, X3 is Y, C, G or S, X4 is I or F, X5 is F or L, X6 is G or E, X7 is E or V, X8 is A or T, X9 is A or V and X10 is absent, F or L. The present invention also provides for the use of the present sequences in identifying animals with altered muscle mass, and for use in selective breeding programs to produce animals with altered muscle mass.
Type:
Application
Filed:
September 30, 2005
Publication date:
May 22, 2008
Applicant:
Orico Limited
Inventors:
Ferenc Jeanplong, Christopher David McMahon
Abstract: The present invention relates to an isolated mimetic of functional myostatin comprising part of the amino acid sequence of functional myostatin, such that the mimetic is capable of inhibiting muscle growth.
Type:
Grant
Filed:
January 18, 2001
Date of Patent:
May 6, 2008
Assignee:
Orico Limited
Inventors:
James Johnston Bass, Carole J. Berry, Ravi Kambadur, Mridula Sharma, Mark F. Thomas
Abstract: A muscle growth regulating factor includes polynucleotide and polypeptide sequences, promoter sequences, constructs comprising the sequences, and compositions for regulating muscle growth and treating diseases associated with muscle growth. The present sequences can be used in identifying animals with altered muscle mass, and for selective breeding programs to produce animals with altered muscle mass.
Type:
Application
Filed:
November 26, 2004
Publication date:
February 28, 2008
Applicant:
Orico Limited
Inventors:
Mridula Sharma, Carole Berry, Mark Thomas, Ravi Kambadur, Robert Bower